Loading clinical trials...
Loading clinical trials...
Phase 1 Study of FCN-437c in Patients With Advanced Solid Tumors
Conditions
Interventions
FCN-437
Locations
3
United States
City of Hope National Medical Center
Duarte, California, United States
Sarah Cannon Research Institute at Tennessee Oncology
Nashville, Tennessee, United States
South Texas Accelerated Research Therapeutics (START)
San Antonio, Texas, United States
Start Date
June 25, 2019
Primary Completion Date
December 8, 2021
Completion Date
December 8, 2021
Last Updated
March 16, 2022
NCT05223608
NCT06625775
NCT06051695
NCT06265727
NCT04665206
NCT05036226
Lead Sponsor
Fochon Pharmaceuticals, Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions